Rooms 2010-2013
20th Floor No. 1018, Changning Road Changning District
Shanghai
China
86 40 0812 1586
https://www.austar.com.hk
Settore/i: Healthcare
Settore: Medical Devices
Impiegati a tempo pieno: 1.610
Nome | Titolo | Retribuzione | Esercitate | Anno di nascita |
---|---|---|---|---|
Mr. Kwok Keung Ho | Founder, Chairman of the Board & CEO | 129,36k | N/D | 1962 |
Mr. Yuewu Chen | Executive Director | 295,12k | N/D | 1966 |
Madam Ning Zhou | Executive Director | 153,3k | N/D | 1973 |
Mr. Kin Hung Ho | Executive Director | 312,41k | N/D | 1957 |
Madam Xiangdi Tang | Vice President of Corporate Development | N/D | N/D | 1978 |
Ms. Yuk Kiu Mak | Company Secretary | N/D | N/D | N/D |
Austar Lifesciences Limited, an investment holding company, engages in the provision of integrated engineering solutions to pharmaceutical manufacturers and research institutes in Mainland China and internationally. The company operates through Liquid and Bioprocess System; Clean Room and Automation Control and Monitoring System; Powder and Solid System; GMP Compliance Service; Life Science Consumables; and Distribution and Agency of Pharmaceutical Equipment segments. It also offers clean utility and bioprocess equipment, clean room, automation control and monitor system; bioprocess equipment consumables, and laboratory solutions. In addition, the company provides pharmaceutical process contamination control; packaging and aseptic containment; biosafety lab animal equipment, and consumables, as well as offers powder and solid equipment; freeze-dryer, sterile filling and visual inspection equipment. Further, it offers project management and process engineering; engineering design and consulting services; operation and maintenance of facility management systems. Additionally, the company provides lifecycle digital solutions and professional consulting services. Austar Lifesciences Limited was founded in 1991 and is headquartered in Shanghai, China.
L'ISS Governance QualityScore di AUSTAR LIFESCIENCE LIMITED al N/D è N/D. I criteri di valutazione fondamentali sono revisione: N/D; Consiglio di Amministrazione: N/D; diritti degli azionisti: N/D; retribuzione: N/D.